Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO_BNOVO NORDISK B A/S | 4.006 T DKK | 903.3 DKK | −1.05% | 2.115 M | 0.54 | 45.37 | 19.91 DKK | +47.53% | 1.04% | Health Technology | Buy |
GMABGENMAB A/S | 134.368 B DKK | 2041 DKK | +0.74% | 71.028 K | 0.60 | 24.65 | 82.78 DKK | +3.37% | 0.00% | Health Technology | Buy |
ZEALZEALAND PHARMA A/S | 37.338 B DKK | 600.0 DKK | −2.99% | 243.223 K | 0.98 | — | −12.52 DKK | +46.15% | 0.00% | Health Technology | Strong buy |
HLUN_AH. LUNDBECK A/S A | 29.706 B DKK | 32.40 DKK | +0.15% | 128.109 K | 0.81 | 13.31 | 2.43 DKK | +1.46% | 2.16% | Health Technology | — |
HLUN_BH. LUNDBECK A/S B | 29.706 B DKK | 37.40 DKK | +0.43% | 652.44 K | 0.85 | 15.36 | 2.43 DKK | +1.46% | 1.87% | Health Technology | Neutral |
BAVABAVARIAN NORDIC A/S | 13.941 B DKK | 178.75 DKK | +3.12% | 918.031 K | 1.52 | 13.94 | 12.82 DKK | +241.38% | 0.00% | Health Technology | Buy |
ORPHAORPHAZYME A/S | 37.049 M DKK | 1049.2 DKK | −0.81% | 18 | 0.40 | — | −737.65 DKK | +95.89% | 0.00% | Health Technology | — |